XML 80 R62.htm IDEA: XBRL DOCUMENT v3.25.2
Segment Information - Segment Information (Details) - Ionis Operations [Member] - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Segment Information [Abstract]        
Revenue $ 452,049 $ 225,250 $ 583,660 $ 344,748
Cost of sales 3,541 3,951 4,904 5,903
Drug discovery 30,255 26,691 57,244 54,862
Drug development 117,689 134,199 230,635 259,951
Medical affairs 7,826 7,092 13,468 11,768
Manufacturing and development chemistry 21,545 14,195 35,826 25,636
R&D support 20,607 17,067 41,159 39,013
Selling, general and administrative 81,081 57,418 148,061 101,151
Other segment items 45,954 30,902 75,750 55,532
Net income (loss) $ 123,551 $ (66,265) $ (23,387) $ (209,068)